Essential thrombocythemia: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
No edit summary |
||
| Line 1: | Line 1: | ||
== Definition == |
== Definition == |
||
| − | * Myelodysplastic disorder of the thrombocytopoeitic stem cells causing a clonal proliferation of thrombocytes |
+ | * [[Myelodysplastic disorder]] of the thrombocytopoeitic stem cells causing a clonal proliferation of thrombocytes |
| − | |||
| ⚫ | |||
| − | |||
| ⚫ | |||
== Clinical Manifestations == |
== Clinical Manifestations == |
||
| Line 18: | Line 14: | ||
** Increased cardiovascular risk |
** Increased cardiovascular risk |
||
** Older than 60 years |
** Older than 60 years |
||
| + | |||
| ⚫ | |||
| ⚫ | |||
== Management == |
== Management == |
||
* Acute |
* Acute |
||
| − | ** If digital or cerebrovascular ischemia, rapid cytoreduction with |
+ | ** If digital or cerebrovascular ischemia, rapid cytoreduction with platelet pheresis |
* Chronic |
* Chronic |
||
| − | ** If high risk, requires cytoreduction and aspirin: |
+ | ** If high risk, requires cytoreduction and [[aspirin]]: |
| − | *** First-line: hydroxyurea |
+ | *** First-line: [[hydroxyurea]] |
| − | *** Alternative: anagrelide |
+ | *** Alternative: [[anagrelide]] |
| − | *** Pregnancy: interferon alfa |
+ | *** Pregnancy: [[interferon alfa]] |
** If >1.5m platelets, requires cytoreduction alone |
** If >1.5m platelets, requires cytoreduction alone |
||
Revision as of 10:24, 20 February 2022
Definition
- Myelodysplastic disorder of the thrombocytopoeitic stem cells causing a clonal proliferation of thrombocytes
Clinical Manifestations
- History
- History of thrombosis or bleeding
- Signs & Symptoms
- Digital ischemia
- Cerebrovascular ischemia
- High risk for vascular events if:
- History of thrombosis or bleeding
- Increased cardiovascular risk
- Older than 60 years
Differential Diagnosis
- Must distinguish from other myelodysplastic disorders (especially polycythemia vera) as well as from secondary causes of thrombocytosis
Management
- Acute
- If digital or cerebrovascular ischemia, rapid cytoreduction with platelet pheresis
- Chronic
- If high risk, requires cytoreduction and aspirin:
- First-line: hydroxyurea
- Alternative: anagrelide
- Pregnancy: interferon alfa
- If >1.5m platelets, requires cytoreduction alone
- If high risk, requires cytoreduction and aspirin:
